05/05/2024
11:15 PM | Molecular Templates (Filer)
| Form EFFECT | |
04/29/2024
8:51 PM | Longitude Capital Partners III, LLC (Filed by)
Molecular Templates (Subject)
| Form SC 13D/A | |
04/25/2024
3:33 PM | Molecular Templates (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/12/2024
3:22 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
7:13 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:57 PM | LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
8:56 PM | Molecular Templates (Subject)
SANTE HEALTH VENTURES I LP (Filed by)
| Form SC 13D/A | |
|
03/29/2024
3:06 PM | Molecular Templates (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024
7:57 AM | Molecular Templates (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2024
7:45 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
7:22 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:08 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:39 PM | Molecular Templates (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
02/14/2024
3:45 PM | K2 HealthVentures Equity Trust LLC (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
02/14/2024
8:33 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
02/13/2024
10:00 AM | BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
01/25/2024
4:32 PM | Molecular Templates (Issuer)
Poma Eric E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:34 PM | Kim Jason S. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:49 PM | Molecular Templates (Issuer)
Voi Maurizio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:45 PM | LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:46 PM | Lanfear Jonathan (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:46 PM | Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:46 PM | Molecular Templates (Issuer)
SELICK HAROLD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:45 PM | Gruia Gabriela (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
5:45 PM | HOFFMANN DAVE (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
3:12 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
4:08 PM | Molecular Templates (Issuer)
Voi Maurizio (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/28/2023
4:01 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
4:08 PM | Molecular Templates (Filer)
| Form DEF 14A | |
09/12/2023
4:12 PM | Molecular Templates (Filer)
| Form DEFA14A | |
09/12/2023
4:15 PM | Molecular Templates (Filer)
| Form ARS | |
08/31/2023
5:22 PM | Gruia Gabriela (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2023
11:15 PM | Molecular Templates (Filer)
| Form EFFECT | |
08/10/2023
8:01 AM | Molecular Templates (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/10/2023
7:18 AM | Molecular Templates (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
7:09 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2023
4:09 PM | LYTTON LAURENCE W (Filed by)
Molecular Templates (Subject)
| Form SC 13G | |
07/19/2023
2:14 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
2:05 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Molecular Templates (Subject)
| Form SC 13G | |
07/18/2023
10:56 AM | Molecular Templates (Filer)
| Form DEF 14A | |
07/13/2023
11:48 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
[URGENT] DO NOT Touch These AI Stocks! (Ad) Artificial intelligence stocks are carrying the market.
One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap.
But is this AI rally over? Click here for our #1 AI Stock for 2024 and Beyond |
06/30/2023
3:31 PM | Molecular Templates (Filer)
| Form PRE 14A | |
06/26/2023
4:27 PM | K2 HealthVentures Equity Trust LLC (Filed by)
Molecular Templates (Subject)
| Form SC 13G | |
06/20/2023
6:00 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
6:59 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
4:16 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
